M.I.TECH Co.Ltd - Asset Resilience Ratio
M.I.TECH Co.Ltd (179290) has an Asset Resilience Ratio of 25.43% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read debt load of M.I.TECH Co.Ltd for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2024)
This chart shows how M.I.TECH Co.Ltd's Asset Resilience Ratio has changed over time. See M.I.TECH Co.Ltd (179290) net assets for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down M.I.TECH Co.Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see M.I.TECH Co.Ltd (179290) market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩34.22 Billion | 25.43% |
| Total Liquid Assets | ₩34.22 Billion | 25.43% |
Asset Resilience Insights
- Very High Liquidity: M.I.TECH Co.Ltd maintains exceptional liquid asset reserves at 25.43% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
M.I.TECH Co.Ltd Industry Peers by Asset Resilience Ratio
Compare M.I.TECH Co.Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087 |
Medical Instruments & Supplies | 9.08% |
|
Vizionfocus Inc.
TW:4771 |
Medical Instruments & Supplies | 5.07% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 4.42% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 51.82% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 6.36% |
|
Austco Healthcare Ltd
AU:AHC |
Medical Instruments & Supplies | 15.90% |
|
Trajan Group Holdings Ltd
AU:TRJ |
Medical Instruments & Supplies | 0.23% |
|
Osteopore Ltd
AU:OSX |
Medical Instruments & Supplies | 43.09% |
Annual Asset Resilience Ratio for M.I.TECH Co.Ltd (2016–2024)
The table below shows the annual Asset Resilience Ratio data for M.I.TECH Co.Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 58.56% | ₩69.41 Billion ≈ $47.04 Million |
₩118.53 Billion ≈ $80.32 Million |
+6.27pp |
| 2023-12-31 | 52.29% | ₩51.68 Billion ≈ $35.03 Million |
₩98.84 Billion ≈ $66.98 Million |
+7.86pp |
| 2022-12-31 | 44.43% | ₩41.79 Billion ≈ $28.32 Million |
₩94.05 Billion ≈ $63.74 Million |
+6.37pp |
| 2021-12-31 | 38.06% | ₩29.89 Billion ≈ $20.25 Million |
₩78.53 Billion ≈ $53.22 Million |
+7.52pp |
| 2020-12-31 | 30.54% | ₩20.79 Billion ≈ $14.09 Million |
₩68.08 Billion ≈ $46.14 Million |
+7.14pp |
| 2019-12-31 | 23.40% | ₩13.41 Billion ≈ $9.09 Million |
₩57.31 Billion ≈ $38.84 Million |
-29.09pp |
| 2018-12-31 | 52.49% | ₩25.85 Billion ≈ $17.52 Million |
₩49.26 Billion ≈ $33.38 Million |
+28.45pp |
| 2017-12-31 | 24.04% | ₩7.13 Billion ≈ $4.83 Million |
₩29.66 Billion ≈ $20.10 Million |
+19.97pp |
| 2016-12-31 | 4.06% | ₩828.37 Million ≈ $561.37K |
₩20.40 Billion ≈ $13.82 Million |
-- |
About M.I.TECH Co.Ltd
M.I.TECH Co.,Ltd engages in the provision of various medical devices in South Korea. The company offers HANAROSTENT, a non-vascular stent; and glucometers under the GBIO BASE and RAPICHECK brand names. It also provides beauty systems, such as BRT system which is used in cleansing skin and inject the effective component in non-invasive way; and ClearView which is used in injecting the effective co… Read more